MicroRNA 1233-1 (MIR1233-1)

MicroRNA 1233-1 (MIR1233-1) is a human non-coding RNA gene that encodes a microRNA involved in post-transcriptional gene regulation.[1] MicroRNAs are typically 20–24 nucleotides in length and function by binding the 3' untranslated regions of target messenger RNAs, causing their degradation or translational repression. MIR1233-1 is transcribed as part of a longer precursor and processed through Drosha and Dicer enzymes to its mature active form. It has been described as a **biomarker for acute pulmonary embolism**, and its mature product, miR-1233-3p, is implicated in the regulation of target genes like GDF15, affecting gastric cancer cell proliferation and prognosis[1][3]. While not a classical drug target (like a protein receptor or enzyme), alterations in its expression, abundance, or activity can contribute to disease and may offer utility for diagnosis, prognosis, or therapeutic modulation in the future.

Other names

MIR1233MIRN1233hsa-mir-1233hsa-mir-1233-1microRNA 1233

For synthetic modulation, likely mechanisms would include: - miRNA mimic to increase MIR1233-1 activity (would suppress translation of target mRNAs) - miRNA inhibitor (antagomir) to reduce MIR1233-1 activity - These approaches could affect downstream target genes like GDF15[3][6] No clinical drugs utilize these mechanisms for MIR1233-1 specifically.